Leadership

Child Health Imprints, Inc.

Child Health Imprints, Inc. is a Delaware corporation based in Madison, WI. Child Health Imprints (CHI) is engaged in the development and application of cutting edge informational and computational technologies including IoT, artificial intelligence machine learning and predictive analytics to the practice of medicine in neonatal intensive care units across the world with the objective of making early diagnosis of critical diseases and improving overall quality of neonatal care.

The company was founded in 2018 and moved its headquarters from Singapore to the US in 2022 to introduce its products already established in Southeast Asia in North America.

Neonatal ICU with ECG monitor on foreground

Management Team

Gene A. Gutman, CEO

Gene is an associate professor / program director of College of Science, Technology, Engineering, Mathematics & Management under the business department. His teaching interests are Supply Chain Mgmt-Supply Chain Design; Negotiation; Procurement and Sourcing; Logistics whereas research interests are Applied Research – Supply Chain Management, Business Strategy, IT Strategy and Implementation, Procurement, Sourcing, Logistics, Transportation, Global Business.

M.S. Management Technology, University of Wisconsin-Stout, Menomonie, WI, 1984
B.S. Emphasis-Production Operations, University of Wisconsin-Stout, Menomonie, WI, 1983

Harpreet Singh PhD, Co-founder

Harpreet sold a previous product to EGI/Philips and Built-Operate-Transfer for Sun Pharma. Over 19 years of healthcare product, research, and development in area of clinical, big data, enterprise platform, and cloud computing systems.

Ph.D., Biomedical Engineering
Developed product in Sleep domain and
Sold to EGI (subsidiary of Philips Medical)
Managed build-operate-transfer for Sun Pharma
Ex-Stryker, Philips, and McKinsey

Ravneet Kaur, Co-founder

Ravneet has over 15 years of experience in building and managing teams, product development, project management and unparalleled client service. Dedicated towards her mission of transforming the knowledge into a product that will predict the critical diseases in a NICU.

M.S. Computer Science, Data Analytics
Developed product in Sleep domain and sold to EGI (subsidiary of PhilipsMedical)
Managed build-operate-transfer for Sun Pharma.

Dr. Mark Joseph Bergeron, Chief Strategy Officer

Dr. Mark Bergeron, MD, MPH, MBA is the Medical Director for Digital Health Transformation at Children’s Minnesota and practices Neonatal-Perinatal Medicine in the Department of Neonatal Medicine. Dr. Bergeron attended medical school at Creighton University in Omaha, Neb. He completed his pediatrics residency at Doernbecher Children’s Hospital at The Oregon Health & Science University in Portland, followed by a neonatal-perinatal medicine fellowship at the University of Minnesota. He holds a master’s degree in public health (Maternal and Child Health) from the University of Minnesota School of Public Health and a master’s in business administration (Health Care) from the University of St. Thomas Opus College of Business in Minneapolis.